Key facts
- Notable investors include Suzhou Oriza Holdings Corporation, Hefei Industry Investment Group, Changda Investment, Jincheng Capital Management, Blue Ocean (Qingdao) — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Rays Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Rays Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Rays Medical
Manufacturer of molecular imaging systems intended for clinical diagnostic and therapeutic use. The company offers full-digital PET/CT and PET/MRI technologies, advanced signal digitization, high-resolution imaging, and specialized anatomical targeting, enabling healthcare institutions to perform earlier and reduce invasive procedures through scalable and innovative medical imaging solutions.
- Sector
- Healthcare
- HQ
- Hefei, China
- Founded
- 2014
- Website
- raysolution.com/
- Ownership
- Privately Held (backing)
Rays Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rays Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rays Medical in its N-PORT filings yet. We sweep new filings monthly.